Core Viewpoint - The company, Beiliang (688793.SH), anticipates a net profit attributable to shareholders of between -105 million to -84 million yuan for the fiscal year 2025, primarily due to strategic adjustments and upgrades in response to industry changes [1] Group 1: Industry Transition and Company Strategy - The smart massage device industry is undergoing a critical transition towards high-quality development, with intensified competition and evolving consumer demands focusing on efficacy and experience [1] - Beiliang's recent performance fluctuations reflect the objective realities of this industry transition, as the company actively adapts to both industry and operational changes [1] - The company is committed to its core strategy of "Traditional Chinese Medicine × Technology," focusing on technological research and development, global expansion, and innovative business models to enhance quality and efficiency [1] Group 2: AI Integration and Product Development - Beiliang is integrating AI as a core direction in product development, combining traditional wellness wisdom with modern technology [2] - The upgraded Chinese constitution identification model, along with AI analysis modules for tongue and pulse, will enable real-time constitution reports based on data from smart wearable devices [2] - Collaborations with tech giants like Alibaba Cloud and Baidu have led to the successful implementation of technologies that enhance user experience and massage precision [2] Group 3: Global Expansion and Brand Development - The company is advancing its globalization strategy by building a comprehensive sales network that integrates online and offline channels, focusing on Southeast Asia and the Middle East [3] - Plans for 2026 include opening 10-20 new offline stores in Southeast Asia, expanding successful models from Thailand to Indonesia and Vietnam [3] - Participation in international exhibitions, such as CES, showcases new products like the AIR3 smart massager and See7R eye massager, enhancing brand visibility and global market penetration [3] Group 4: Innovative Business Models and Growth Opportunities - Beiliang is launching the "Easy Moment" health management brand in 2025, combining self-developed technology products with manual massage and moxibustion therapy to create a hybrid business model [4] - Strategic partnerships with leading automotive companies like BYD and Chery are being formed to explore health solutions in the automotive sector, opening new growth channels [4] - The company is also addressing the aging population by developing products tailored for elderly users, with 13 products already included in a government initiative for smart home upgrades [4] Group 5: Long-term Development and Market Positioning - Through the integration of "Traditional Chinese Medicine × Technology" and diverse business models, Beiliang is continuously expanding its growth boundaries and strengthening its brand presence in both domestic and international markets [5]

Core Insights - The article highlights the participation of Chinese health technology leader Beike (stock code: 688793) at the 2026 International Consumer Electronics Show (CES), showcasing its innovative products and global brand strategy [1][5]. Group 1: Product Launch and Innovation - Beike unveiled two flagship products, the AIR3 smart massage device and the See 7R eye care device, emphasizing the integration of AI technology in health solutions [4]. - The AIR3 smart massage device features a unique 5-second quick storage system and AI algorithms for personalized support, redefining travel comfort with its multifunctional capabilities [4]. - The See 7R eye massage device addresses dry eye syndrome through a three-step bionic therapy model, combining advanced technology with professional care techniques [4]. Group 2: Strategic Global Expansion - Beike's presence at CES is a significant step in its global strategy, following its successful market entry in Southeast Asia, including Singapore and Malaysia, where it achieved profitability [5]. - The company plans to implement a "one country, one policy" strategy for market expansion, focusing on both direct sales and franchise models in various Southeast Asian countries [5]. - The CES participation serves as a global validation of Beike's "technology × traditional Chinese medicine" concept and signals its commitment to international growth [5][6]. Group 3: Market Trends and Future Outlook - Industry analysis suggests that Beike is well-positioned to capitalize on the dual trends of global health consumption and AI technology proliferation, with a clear global strategy and proven profitability model [7]. - The CES showcase not only demonstrates Beike's product and technological capabilities but also aims to enhance its brand valuation in the global health technology market [7]. - The ongoing CES event, which runs until January 9, is attracting attention from global partners, media, and consumers, accelerating Beike's journey in the health technology sector [7].